4.6 Article

Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease

期刊

PLOS ONE
卷 7, 期 9, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0044156

关键词

-

资金

  1. National Cancer Institute
  2. Danish Cancer Society
  3. Danish National Research Foundation
  4. European Commission
  5. Grants-in-Aid for Scientific Research [22590307] Funding Source: KAKEN

向作者/读者索取更多资源

Background: Cellular senescence can be a functional barrier to carcinogenesis. We hypothesized that inflammation modulates carcinogenesis through senescence and DNA damage response (DDR). We examined the association between senescence and DDR with macrophage levels in inflammatory bowel disease (IBD). In vitro experiments tested the ability of macrophages to induce senescence in primary cells. Inflammation modulating microRNAs were identified in senescence colon tissue for further investigation. Methodology/Principal Findings: Quantitative immunohistochemistry identified protein expression by colon cell type. Increased cellular senescence (HP1 gamma; P = 0.01) or DDR (gamma H2A.X; P = 0.031, phospho-Chk2, P = 0.014) was associated with high macrophage infiltration in UC. Co-culture with macrophages (ANA-1) induced senescence in .80% of primary cells (fibroblasts MRC5, WI38), illustrating that macrophages induce senescence. Interestingly, macrophage-induced senescence was partly dependent on nitric oxide synthase, and clinically relevant NO center dot levels alone induced senescence. NO center dot induced DDR in vitro, as detected by immunofluorescence. In contrast to UC, we noted in Crohn's disease (CD) that senescence (HP1 gamma; P < 0.001) and DDR (gamma H2A.X; P < 0.05, phospho-Chk2; P < 0.001) were higher, and macrophages were not associated with senescence. We hypothesize that nitric oxide may modulate senescence in CD; epithelial cells of CD had higher levels of NOS2 expression than in UC (P = 0.001). Microarrays and quantitative-PCR identified miR-21 expression associated with macrophage infiltration and NOS2 expression. Conclusions: Senescence was observed in IBD with senescence-associated beta-galactosidase and HP1 gamma. Macrophages were associated with senescence and DDR in UC, and in vitro experiments with primary human cells showed that macrophages induce senescence, partly through NO center dot, and that NO center dot can induce DDR associated with senescence. Future experiments will investigate the role of NO center dot and miR-21 in senescence. This is the first study to implicate macrophages and nitrosative stress in a direct effect on senescence and DDR, which is relevant to many diseases of inflammation, cancer, and aging.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

Chen Huang, Lijun Chen, Sara R. Savage, Rodrigo Vargas Eguez, Yongchao Dou, Yize Li, Felipe da Veiga Leprevost, Eric J. Jaehnig, Jonathan T. Lei, Bo Wen, Michael Schnaubelt, Karsten Krug, Xiaoyu Song, Marcin Cieslik, Hui-Yin Chang, Matthew A. Wyczalkowski, Kai Li, Antonio Colaprico, Qing Kay Li, David J. Clark, Yingwei Hu, Liwei Cao, Jianbo Pan, Yuefan Wang, Kyung-Cho Cho, Zhiao Shi, Yuxing Liao, Wen Jiang, Meenakshi Anurag, Jiayi Ji, Seungyeul Yoo, Daniel Cui Zhou, Wen-Wei Liang, Michael Wendl, Pankaj Vats, Steven A. Carr, D. R. Mani, Zhen Zhang, Jiang Qian, Xi S. Chen, Alexander R. Pico, Pei Wang, Arul M. Chinnaiyan, Karen A. Ketchum, Christopher R. Kinsinger, Ana Robles, Eunkyung An, Tara Hiltke, Mehdi Mesri, Mathangi Thiagarajan, Alissa M. Weaver, Andrew G. Sikora, Jan Lubinski, Malgorzata Wierzbicka, Maciej Wiznerowicz, Shankha Satpathy, Michael A. Gillette, George Miles, Matthew J. Ellis, Gilbert S. Omenn, Henry Rodriguez, Emily S. Boja, Saravana M. Dhanasekaran, Li Ding, Alexey Nesvizhskii, Adel K. El-Naggar, Daniel W. Chan, Hui Zhang, Bing Zhang

Summary: This study presents a proteogenomic analysis of HPV-negative HNSCCs, identifying potential therapeutic targets and uncovering tumor characteristics such as immune status and resistance mechanisms. The findings suggest new strategies for stratifying HNSCC and improving treatment outcomes.

CANCER CELL (2021)

Article Oncology

Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang, Alla Karpova, Marina A. Gritsenko, Jennifer E. Kyle, Song Cao, Yize Li, Dmitry Rykunov, Antonio Colaprico, Joseph H. Rothstein, Runyu Hong, Vasileios Stathias, MacIntosh Cornwell, Francesca Petralia, Yige Wu, Boris Reva, Karsten Krug, Pietro Pugliese, Emily Kawaler, Lindsey K. Olsen, Wen-Wei Liang, Xiaoyu Song, Yongchao Dou, Michael C. Wendl, Wagma Caravan, Wenke Liu, Daniel Cui Zhou, Jiayi Ji, Chia-Feng Tsai, Vladislav A. Petyuk, Jamie Moon, Weiping Ma, Rosalie K. Chu, Karl K. Weitz, Ronald J. Moore, Matthew E. Monroe, Rui Zhao, Xiaolu Yang, Seungyeul Yoo, Azra Krek, Alexis Demopoulos, Houxiang Zhu, Matthew A. Wyczalkowski, Joshua F. McMichael, Brittany L. Henderson, Caleb M. Lindgren, Hannah Boekweg, Shuangjia Lu, Jessika Baral, Lijun Yao, Kelly G. Stratton, Lisa M. Bramer, Erika Zink, Sneha P. Couvillion, Kent J. Bloodsworth, Shankha Satpathy, Weiva Sieh, Simina M. Boca, Stephan Schurer, Feng Chen, Maciej Wiznerowicz, Karen A. Ketchum, Emily S. Boja, Christopher R. Kinsinger, Ana Robles, Tara Hiltke, Mathangi Thiagarajan, Alexey Nesvizhskii, Bing Zhang, D. R. Mani, Michele Ceccarelli, Xi S. Chen, Sandra L. Cottingham, Qing Kay Li, Albert H. Kim, David Fenyo, Kelly Ruggles, Henry Rodriguez, Mehdi Mesri, Samuel H. Payne, Adam C. Resnick, Pei Wang, Richard D. Smith, Antonio Iavarone, Milan G. Chheda, Jill S. Barnholtz-Sloan, Karin D. Rodland, Tao Liu, Li Ding

Summary: Understanding the molecular pathogenesis of glioblastoma is crucial for improving diagnosis and treatment. Integrated analysis of genomic, proteomic, and metabolomic data on treatment-naive glioblastomas has identified key phosphorylation events and potential targets for specific tumor alterations. Immune subtypes with distinct immune cell types were discovered, and specific histone acetylation patterns were correlated with these subtypes, providing insights for stratification of patients for more effective treatment.

CANCER CELL (2021)

Article Oncology

EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells

Akihiko Miyanaga, Masaru Matsumoto, Jessica A. Beck, Izumi Horikawa, Takahiro Oike, Hirokazu Okayama, Hiromi Tanaka, Sandra S. Burkett, Ana I. Robles, Mohammed Khan, Delphine Lissa, Masahiro Seike, Akihiko Gemma, Hiroyuki Mano, Curtis C. Harris

Summary: Chromosomal inversions involving ALK and EML4 generate fusion protein EML4-ALK in NSCLC. Functional study on normal human cells revealed that EML4-ALK induces cellular senescence and accelerated proliferation, with different signaling pathways contributing to the phenotypic outcomes. The expression of hTERT is critical for EML4-ALK to manifest its in vitro transforming activity in human cells.

BMC CANCER (2021)

Editorial Material Multidisciplinary Sciences

Comment on Evidence that the ProPerDP method is inadequate for protein persulfidation detection due to lack of specificity

Eva Doka, Elias S. J. Arner, Edward E. Schmidt, Tobias P. Dick, Albert van der Vliet, Jing Yang, Reka Szatmari, Tamas Ditroi, John L. Wallace, Giuseppe Cirino, Kenneth Olson, Hozumi Motohashi, Jon M. Fukuto, Michael D. Pluth, Martin Feelisch, Takaaki Akaike, David A. Wink, Louis J. Ignarro, Peter Nagy

Summary: The recent report by Fan et al. alleging the inadequacy of the ProPerDP method for protein persulfidation detection is not supported by their data and is based on methodological shortcomings. Their assumptions and conclusions have not been confirmed by other methods.

SCIENCE ADVANCES (2021)

Article Biology

An in vitro tumorigenesis model based on live-cell-generated oxygen and nutrient gradients

Anne C. Gilmore, Sarah J. Flaherty, Veena Somasundaram, David A. Scheiblin, Stephen J. Lockett, David A. Wink, William F. Heinz

Summary: The study presents a 2D live-cell chamber that approximates the tumor microenvironment, demonstrating how breast cancer cells and macrophages generate gradients and self-organize. This in vitro tumorigenesis model simplifies the study of cancer cell behavior in different microenvironment conditions.

COMMUNICATIONS BIOLOGY (2021)

Article Oncology

Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer

Hanna T. Sjoberg, Yiannis Philippou, Anette L. Magnussen, Iain D. C. Tullis, Esther Bridges, Andrea Chatrian, Joel Lefebvre, Ka Ho Tam, Emma A. Murphy, Jens Rittscher, Dina Preise, Lilach Agemy, Tamar Yechezkel, Sean C. Smart, Paul Kinchesh, Stuart Gilchrist, Danny P. Allen, David A. Scheiblin, Stephen J. Lockett, David A. Wink, Alastair D. Lamb, Ian G. Mills, Adrian Harris, Ruth J. Muschel, Boris Vojnovic, Avigdor Scherz, Freddie C. Hamdy, Richard J. Bryant

Summary: The study investigated the combination of fractionated radiotherapy (FRT) and vascular-targeted photodynamic therapy (VTP) in treating prostate cancer (PCa). Results showed that FRT induced vascular normalization changes in PCa tumors, and the sequential delivery of FRT followed by VTP significantly delayed tumor growth and improved overall survival in pre-clinical models. The findings suggest that combining FRT and VTP may be a promising multimodal approach in PCa therapy, which could inform early phase clinical trials.

BRITISH JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Liwei Cao, Chen Huang, Daniel Cui Zhou, Yingwei Hu, T. Mamie Lih, Sara R. Savage, Karsten Krug, David J. Clark, Michael Schnaubelt, Lijun Chen, Felipe da Veiga Leprevost, Rodrigo Vargas Eguez, Weiming Yang, Jianbo Pan, Bo Wen, Yongchao Dou, Wen Jiang, Yuxing Liao, Zhiao Shi, Nadezhda Terekhanova, Song Cao, Rita Jui-Hsien Lu, Yize Li, Ruiyang Liu, Houxiang Zhu, Peter Ronning, Yige Wu, Matthew A. Wyczalkowski, Hariharan Easwaran, Ludmila Danilova, Arvind Singh Mer, Seungyeul Yoo, Joshua M. Wang, Wenke Liu, Benjamin Haibe-Kains, Mathangi Thiagarajan, Scott D. Jewell, Galen Hostetter, Chelsea J. Newton, Qing Kay Li, Michael H. Roehr, David Fenyo, Pei Wang, Alexey Nesvizhskii, D. R. Mani, Gilbert S. Omenn, Emily S. Boja, Mehdi Mesri, Ana Robles, Henry Rodriguez, Oliver F. Bathe, Daniel W. Chan, Ralph H. Hruban, Li Ding, Bing Zhang, Hui Zhang

Summary: This study conducted comprehensive proteogenomic analysis of PDAC to understand the molecular alterations that drive oncogenesis. Multiple analyses were performed on tissues from patients, providing valuable resources for early detection and identification of therapeutic targets.
Review Biochemistry & Molecular Biology

Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment

Christopher L. McGinity, Erika M. Palmieri, Veena Somasundaram, Dibyangana D. Bhattacharyya, Lisa A. Ridnour, Robert Y. S. Cheng, Aideen E. Ryan, Sharon A. Glynn, Douglas D. Thomas, Katrina M. Miranda, Stephen K. Anderson, Stephen J. Lockett, Daniel W. McVicar, David A. Wink

Summary: The metabolic requirements and functions of cancer and normal tissues differ significantly, with distorted vasculature and hypoxia-induced stress commonly observed in tumor microenvironments. Recent studies have shown that alterations in various metabolic pathways dictate tumor behavior and response to therapy, with metabolic heterogeneity within the tumor microenvironment playing a key role in promoting tumor behavior.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Inorganic & Nuclear

Nitric Oxide and Cancer: When to Give and When to Take Away?

Katrina M. Miranda, Lisa A. Ridnour, Christopher L. McGinity, Dana Bhattacharyya, David A. Wink

Summary: The mechanistic roles of nitric oxide (NO) in cancer progression are complex, with both pro-and antitumorigenic effects. Understanding the concentration, spatial, and temporal dependence of responses to NO is crucial for developing effective cancer treatments.

INORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation

Daniele Mancardi, Pasquale Pagliaro, Lisa A. Ridnour, Carlo G. Tocchetti, Katrina Miranda, Magdalena Juhaszova, Steven J. Sollott, David A. Wink, Nazareno Paolocci

Summary: Nitroxyl (HNO), the one electron-reduction product of nitric oxide (NO), can limit ischemia-reperfusion (I/R) injury by inhibiting the opening of mitochondrial permeability transition pore (mPTP). This study provides insights into the mechanisms of HNO-mediated cardioprotection.

ANTIOXIDANTS (2022)

Review Oncology

Targeting Nitric Oxide: Say NO to Metastasis

Tejaswini P. Reddy, Sharon A. Glynn, Timothy R. Billiar, David A. Wink, Jenny C. Chang

Summary: Targeted therapies that reduce cancer metastasis, target chemoresistant cancer stem cells, and enhance the efficacy of systemic chemo/radiotherapies are crucial in reducing cancer-related mortality. Targeting nitric oxide synthase (NOS), a protein in the tumor microenvironment, has shown promise as a therapeutic strategy in various solid malignancies. This review examines the role of nitric oxide (NO) in tumor progression and metastasis, as well as preclinical studies evaluating NOS inhibitors as anticancer therapies. The prospects and challenges of using NOS inhibitors in a clinical setting are also discussed.

CLINICAL CANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density

Veena Somasundaram, Lisa A. Ridnour, Robert Ys Cheng, Abigail J. Walke, Noemi Kedei, Dibyangana D. Bhattacharyya, Adelaide L. Wink, Elijah F. Edmondson, Donna Butcher, Andrew C. Warner, Tiffany H. Dorsey, David A. Scheiblin, William Heinz, Richard J. Bryant, Robert J. Kinders, Stanley Lipkowitz, Stephen T. C. Wong, Milind Pore, Stephen M. Hewitt, Daniel W. McVicar, Stephen K. Anderson, Jenny Chang, Sharon A. Glynn, Stefan Ambs, Stephen J. Lockett, David A. Wink

Summary: The levels of NOS2/COX2 in tumors influence the polarization and spatial location of lymphoid cells, including CD8(+) T cells. High levels of NOS2/COX2 are associated with the exclusion of CD8(+) T cells from the tumor epithelium. The drug inhibitor indomethacin can improve the penetration ability of CD8(+) T cells and reduce tumor growth, leading to tumor regression.

REDOX BIOLOGY (2022)

Article Biochemistry & Molecular Biology

A New Chemotactic Mechanism Governs Long-Range Angiogenesis Induced by Patching an Arterial Graft into a Vein

Dhisa Minerva, Nuha Loling Othman, Takashi Nakazawa, Yukinobu Ito, Makoto Yoshida, Akiteru Goto, Takashi Suzuki

Summary: Chemotaxis plays an important role in angiogenesis, but in arterial patch grafting-induced angiogenesis, the VEGFA concentration gradient is decreasing. The formation of new blood vessels shows twisted and congested morphology, distinguishable from non-pathological vessels. Through a mathematical model and numerical simulations, we found that the growth speed of new vessels oscillates and observed crowded and congested blood vessel formation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

暂无数据